Updated: April 2, 2026
How Does Letrozole Work? Mechanism of Action Explained in Plain English
Author
Peter Daggett

- Step 1: Why Estrogen Matters for Breast Cancer
- Step 2: The Aromatase Enzyme — The Factory That Makes Estrogen
- Step 3: How Letrozole Shuts Down Estrogen Production
- How Letrozole Compares to Tamoxifen
- Why Is Letrozole Specific to Postmenopausal Women?
- How Letrozole Works for Fertility Treatment
- Highly Selective: Letrozole Doesn't Affect Adrenal Hormones
Overview
How does Letrozole actually fight breast cancer or support fertility? This plain-English guide explains the science behind aromatase inhibition and estrogen suppression.
Is Letrozole in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Letrozole near you.
"It blocks estrogen" — most patients have heard this explanation of how Letrozole works. But what does that actually mean? How does blocking one hormone fight cancer or help someone get pregnant? This guide breaks down the science of Letrozole in language anyone can understand.
Step 1: Why Estrogen Matters for Breast Cancer
About 70-80% of all breast cancers are what doctors call "hormone receptor-positive" (HR+). This means the cancer cells have receptors — basically docking stations — for estrogen. When estrogen binds to these receptors, it acts like a switch that tells cancer cells to grow and multiply.
The logical treatment strategy: if cancer cells need estrogen to grow, remove the estrogen. That's exactly what Letrozole does.
Check live stock now.
Step 2: The Aromatase Enzyme — The Factory That Makes Estrogen
After menopause, the ovaries stop producing estrogen. But estrogen doesn't disappear entirely — it's still made in fat tissue, muscle, and other tissues throughout the body. The key player is an enzyme called aromatase.
Aromatase is a biological factory. Its job is to take androgens (male hormones like testosterone and androstenedione) that circulate throughout the body and convert them into estrogens (specifically estrone and estradiol). Without aromatase, this conversion doesn't happen and estrogen levels drop significantly.
Step 3: How Letrozole Shuts Down Estrogen Production
Letrozole is an aromatase inhibitor — it competitively binds to the aromatase enzyme at its active site (specifically the heme group of the enzyme's cytochrome P450 component). Think of it like a key that gets stuck in a lock, preventing any other key from working. Once Letrozole binds, aromatase can no longer do its job of converting androgens to estrogens.
The result is dramatic: Letrozole suppresses estrogen levels by more than 99% in postmenopausal women. With estrogen removed, hormone receptor-positive breast cancer cells lose the signal that tells them to grow. Growth slows, stops, or in some cases cancer cells die.
How Letrozole Compares to Tamoxifen
Many patients wonder how Letrozole differs from tamoxifen, another common breast cancer drug. The difference lies in mechanism:
Letrozole stops estrogen from being produced in the first place — it attacks the hormone supply
Tamoxifen allows estrogen to be produced, but blocks it from binding to cancer cell receptors — it attacks the hormone's ability to dock
This is why Letrozole is preferred for postmenopausal women (where aromatase is the main source of estrogen) and tamoxifen is preferred for premenopausal women (where the ovaries are the main estrogen source and aromatase inhibitors are less effective).
Why Is Letrozole Specific to Postmenopausal Women?
Before menopause, the ovaries are the primary source of estrogen, and they don't use aromatase — they produce estrogen directly through a different pathway. Letrozole only blocks the aromatase pathway, so it can't stop the ovaries from making estrogen. This is why Letrozole isn't effective (and isn't FDA-approved) as a standalone therapy for premenopausal women with breast cancer. Premenopausal women would need ovarian suppression in addition to Letrozole for it to work effectively.
How Letrozole Works for Fertility Treatment
In fertility treatment, Letrozole's mechanism works differently — and somewhat paradoxically. Here's the logic:
When Letrozole temporarily suppresses estrogen production (for just 5 days), the brain's hypothalamus and pituitary gland sense the low estrogen.
In response, the pituitary releases more follicle-stimulating hormone (FSH), which stimulates the ovaries to recruit and develop egg follicles.
When Letrozole is stopped after 5 days, estrogen levels rebound and ovulation follows.
Because Letrozole has a short half-life of about 2 days (versus clomiphene's much longer half-life), it clears quickly from the system, allowing estrogen to rise naturally to support implantation. This is one reason letrozole is associated with better endometrial lining thickness and higher pregnancy rates compared to clomiphene in PCOS patients.
Found
Rate
on average
Highly Selective: Letrozole Doesn't Affect Adrenal Hormones
An important feature of Letrozole is its high selectivity for aromatase. Unlike some older hormone-blocking drugs, Letrozole does not impair adrenal steroidogenesis. This means it doesn't significantly affect production of cortisol, aldosterone, or other adrenal hormones — glucocorticoid supplementation is not required during Letrozole therapy.
For a full overview of Letrozole including dosage and uses, see What Is Letrozole? Uses, Dosage, and What You Need to Know. And if you need help finding Letrozole at a pharmacy near you, medfinder can help.
Frequently Asked Questions
Letrozole competitively binds to the aromatase enzyme's active site (the heme group of its cytochrome P450 component), blocking the enzyme from converting androgens into estrogens. This reduces estrogen levels in postmenopausal women by more than 99%.
Letrozole stops estrogen from being produced by blocking the aromatase enzyme. Tamoxifen allows estrogen to be produced but blocks it from binding to cancer cell receptors. Letrozole is preferred for postmenopausal women; tamoxifen is typically preferred for premenopausal women.
Before menopause, the ovaries produce estrogen through a pathway that doesn't involve aromatase. Since Letrozole only blocks aromatase, it can't stop the ovaries from making estrogen. For breast cancer treatment, Letrozole is therefore only indicated for postmenopausal women (or premenopausal women receiving ovarian suppression).
Letrozole temporarily suppresses estrogen for 5 days, causing the pituitary gland to release more FSH (follicle-stimulating hormone). This stimulates the ovaries to develop egg follicles. When Letrozole is stopped, estrogen rebounds and ovulation occurs. Its short half-life (2 days) also means it clears quickly, preserving a good uterine lining for implantation.
Letrozole is highly selective for aromatase and does not significantly affect adrenal hormones like cortisol or aldosterone. Studies have shown no clinically relevant changes in cortisol or ACTH-stimulated hormone production during Letrozole therapy, so no supplemental steroids are needed.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Letrozole also looked for:
More about Letrozole
38,353 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





